| Predicate |
Object |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2250-0096
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2430-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2250-0002
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2250-0067 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F9-0017
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F9-00781
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F9-0026 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F9-007 |
| filingDate |
2019-02-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate |
2021-06-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-2021514719-A |
| titleOfInvention |
Ocular implants and delivery system |
| abstract |
The ocular implant contains a drug-releasing element and has an inlet portion and a Schlemm's canal portion distal to the inlet portion. When the entrance portion is placed at the proximal end of the implant and is sized and configured to be placed within the anterior chamber of the human eye, and the Schlemm's canal portion is placed within the anterior chamber of the entrance. Arranged and configured to be located within the Schlemm's canal of the eye. |
| priorityDate |
2018-02-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |